COVID-19, caused by the SARS-CoV-2 virus, is a respiratory infectious disease. While most
patients recover after treatment, there is growing evidence that COVID-19 may result in …

Abstract Many Coronavirus Disease 2019 (COVID-19) patients are suffering from long-term
neuropsychological sequelae. These patients may benefit from a better understanding of the …

Type I interferon signaling (IFN-I) perturbations are major drivers of COVID-19. Dysregulated
IFN-I in the brain, however, has been linked to both reduced cognitive resilience and …

Recovered COVID-19 patients frequently suffer of cognitive disorders. Several
etiopathogenetic mechanisms have been considered for the brain complications in COVID …

Introduction The COVID-19 pandemic has affected millions worldwide, causing mortality and
multi-organ morbidity. Neurological complications have been recognized. This study aimed …

COVID-19's effects on the human brain reveal a multifactorial impact on cognition and the
potential to inflict lasting neuronal damage. Type I interferon signaling, a pathway that …

Olfaction is understudied in neuroimaging research compared to other senses, but there is
growing evidence of its therapeutic benefits on mood and well-being. Olfactory imagery can …

Introduction Olfactory dysfunction (OD) is frequent after SARS-CoV-2 infection. The aim of
this study was to examine if long-term OD is common in post-COVID condition, and the …

Olfactory dysfunction (OD) is one of the most common symptoms in COVID-19 patients and
can impact patients' lives significantly. The aim of this review was to investigate the …

Post-COVID conditions (PCCs) cover a wide spectrum of lingering symptoms experienced
by survivors of coronavirus disease 2019 (COVID-19). Neurological and neuropsychiatric …